05:39 PM EDT, 10/08/2025 (MT Newswires) -- Ryan Cohlhepp, Director, President and COO, on October 06, 2025, sold 50,500 shares in Bicara Therapeutics ( BCAX ) for $911,842. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 202,641 common shares of the company, with 202,641 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000203466525000004/xslF345X05/wk-form4_1759959205.xml